BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11212325)

  • 1. Proteasomes in apoptosis: villains or guardians?
    Wójcik C
    Cell Mol Life Sci; 1999 Dec; 56(11-12):908-17. PubMed ID: 11212325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration that a human 26S proteolytic complex consists of a proteasome and multiple associated protein components and hydrolyzes ATP and ubiquitin-ligated proteins by closely linked mechanisms.
    Kanayama HO; Tamura T; Ugai S; Kagawa S; Tanahashi N; Yoshimura T; Tanaka K; Ichihara A
    Eur J Biochem; 1992 Jun; 206(2):567-78. PubMed ID: 1317798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apoptosis by the ubiquitin and proteasome pathway.
    Wójcik C
    J Cell Mol Med; 2002; 6(1):25-48. PubMed ID: 12003667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway.
    Dimmeler S; Breitschopf K; Haendeler J; Zeiher AM
    J Exp Med; 1999 Jun; 189(11):1815-22. PubMed ID: 10359585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mdm2 and bax, downstream mediators of the p53 response, are degraded by the ubiquitin-proteasome pathway.
    Chang YC; Lee YS; Tejima T; Tanaka K; Omura S; Heintz NH; Mitsui Y; Magae J
    Cell Growth Differ; 1998 Jan; 9(1):79-84. PubMed ID: 9438391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells.
    Fukazawa T; Fujiwara T; Uno F; Teraishi F; Kadowaki Y; Itoshima T; Takata Y; Kagawa S; Roth JA; Tschopp J; Tanaka N
    Oncogene; 2001 Aug; 20(37):5225-31. PubMed ID: 11526513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.
    Palombella VJ; Conner EM; Fuseler JW; Destree A; Davis JM; Laroux FS; Wolf RE; Huang J; Brand S; Elliott PJ; Lazarus D; McCormack T; Parent L; Stein R; Adams J; Grisham MB
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15671-6. PubMed ID: 9861028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.
    Li B; Dou QP
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):3850-5. PubMed ID: 10725400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.
    Zhang XM; Lin H; Chen C; Chen BD
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):127-33. PubMed ID: 10229667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.
    Mullally JE; Moos PJ; Edes K; Fitzpatrick FA
    J Biol Chem; 2001 Aug; 276(32):30366-73. PubMed ID: 11390388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulating protein degradation by ubiquitination.
    Weissman AM
    Immunol Today; 1997 Apr; 18(4):189-98. PubMed ID: 9136456
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
    J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system.
    Smith L; Chen L; Reyland ME; DeVries TA; Talanian RV; Omura S; Smith JB
    J Biol Chem; 2000 Dec; 275(51):40620-7. PubMed ID: 11016947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis].
    Hilt W; Wolf DH
    Naturwissenschaften; 1995 Jun; 82(6):257-68. PubMed ID: 7643904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the ubiquitin-proteasome pathway in apoptosis.
    Orlowski RZ
    Cell Death Differ; 1999 Apr; 6(4):303-13. PubMed ID: 10381632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome.
    Kleijnen MF; Alarcon RM; Howley PM
    Mol Biol Cell; 2003 Sep; 14(9):3868-75. PubMed ID: 12972570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proteasome function induced apoptosis in gastric cancer.
    Fan XM; Wong BC; Wang WP; Zhou XM; Cho CH; Yuen ST; Leung SY; Lin MC; Kung HF; Lam SK
    Int J Cancer; 2001 Aug; 93(4):481-8. PubMed ID: 11477551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons.
    Qiu JH; Asai A; Chi S; Saito N; Hamada H; Kirino T
    J Neurosci; 2000 Jan; 20(1):259-65. PubMed ID: 10627603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.